Bio-Rad Laboratories, Inc.

BIO Healthcare Medical Devices

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue
+0.52%
EPS
+234.9%
Free cash flow
+8.07%
Total debt
+0.11%

Quarter to September 2026, against a year earlier

381.91 12.91 +3.50%
Market cap
$9.9B
P/E
9.7×
Fwd P/E
44.7×
Dividend yield
—
F-score
5/9
Altman Z
3.20
Beneish M
−2.29
Dividend safety
n/a

Bio-Rad Laboratories, Inc. (BIO) Net income

Alert me on Net income

Over the twelve months to 30 June 2026 it was $616.6M. Bio-Rad Laboratories, Inc. ranks 12th of 149 Medical Devices companies by net income.

Net income, annual

No history to chart for BIO yet.

Annual newest first

Period Net income Change

Quarterly newest first

Period Net income Change
Jun 2026 $371.4M —
Sep 2025 −$341.9M —
Jun 2025 $317.8M 18.01%
Sep 2018 $269.3M 0.47%
14 more quarters

Net income against peers

What Net income is

Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.

Reported line item

The full definition of Net income →

More on BIO